Pluripotent stem cells are totally different from other cells, such as cancer cell lines and primary cells. Cancer cells divide infinitely, but their differentiation status does not change. Primary cells divide only into limited numbers and change their characteristics as they divide. Pluripotency, therefore, has been the main focus of stem cell research.
Regenerative medicine is to replace or transplant cells or tissues to restore normal function. For the generation of cells or tissues, cell source has been a major problem. Pluripotent stem cells produce cells of three germ layers. That is all the somatic cells could be derived from pluripotent stem cells virtually. Embryonic stem ES cells have been expected to be a cell source for the transplantation of patients with organ failure.
Embryonic carcinoma EC cells, extracted from teratocarcinoma, have such characters. EC cells not only divide infinitely, but also produce cells of three germ layers [ ]. These characters fulfill the criteria of pluripotency. EC cells are the first cells that have been reported to exhibit pluripotency. EC cells are successful in the formation of chimera in germ line and in the production of chimera mice. Researchers were excited about the results expecting that genetically modified mice would be produced. Disappointingly, cancer develops in the chimera mice. Researchers speculate that one of the major reasons of cancer is the formation of EC cells.
With the experience of EC cells, researchers attempted to derive cells from a healthy embryo. Mouse embryonic stem cells were first extracted in , and human ES cells were first extracted in [ , ] . ES cells are derived from the inner cell mass of preimplantation embryos. ES cells have been used to produce knockout mice.
To produce ES cells, embryos need to be broken. This raises ethical issues. The transplantation of cells or tissues produced from ES cells causes graft-versus-host disease GVHD . Ethical issues and GVHD are innate obstacles to develop regenerative medicine.
To overcome these problems, methods to produce human-induced pluripotent stem iPS For the clinical application of iPS cells, new problems arise, that is, culture methods. To transplant somatic cells differentiated from iPS cells, the iPS cells should be manipulated under xeno-free condition. "nother problem with manipulation is that a good-medical-practice GMP level should be realized.
Practically, the extraction of iPS cells from a patient requires plenty of time and labor. If iPS cells are stored and provided upon request, time and labor would be saved. Patients would be subjected to regenerative medicine promptly and smoothly. iPS cell banks have been under development with dental pulp [ ].
From a pharmacological point of view, somatic cells and tissues are necessary for the evaluation of toxicity of certain types of drugs. Human cells or tissues are very hard to obtain for the investigation of toxicity. iPS cells are expected to be useful for toxicology because they would produce somatic cells in the toxicological experiments.
To innovate a drug for the treatment of a disease, the mechanism of the disease should be clarified. "s mentioned earlier, it is difficult to obtain somatic cells or tissues from the patients. iPS cells are again expected to be useful for the investigation of the mechanism of the disease because they would differentiate into somatic cells.
With the above discussions, the differentiation of iPS cells has been the main focus of the investigation. There have been plenty of literatures on differentiation protocols of iPS cells. Unfortunately, some somatic cells are difficult to obtain from iPS cells.
During the investigation of differentiation protocols, a new concept arises, that is, selforganization [ ]. iPS cells differentiate into various types of cells forming an organ. The
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Mesenchymal stem cells MSCs are usually obtained from bone marrow. MSCs have the potential to differentiate into adipose cells, chondrocytes, and hematopoietic cells. MSCs can be obtained from a potential recipient and differentiated into target cells. MSCs, therefore, are considered interesting and useful for the scientific and clinical applications.
This book demonstrates the current status of stem cell research, new concepts, and solutions to the problems of pluripotent stem cells. Finally, it is shown how the issues are addressed, and horizons of accumulated and broadened knowledge.
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